The primary objective of the Pediatric Hematology Research Training Program, which will complete its 35th year of funding in 2011, has been to prepare individuals interested in pediatric hematology for careers in academic medicine and biomedical research.
Specific aims i nclude (1) the provision of research training opportunities in a wide variety of basic and clinical research areas including hemoglobinopathies, megakaryocytes and platelets., immunohematology, stem cell development, molecular diagnostic techniques, molecular basis of hemostasis, and gene therapy for hematologic disorders;(2) the opportunity for structured coursework in cell and molecular biology, immunology, biochemistry, gene transfer, biostatistics, epidemiology and research design;(3) careful monitoring of the progress of individual trainees and the overall success of the training program;and (4) an emphasis on skills and accomplishments critical for successful academic careers such as preparation of manuscripts, presentations at seminars and national meetings, and submission of grant applications. The training faculty consists of a closely-knit group of physicians and scientists who have strong records as mentors and productive investigators, who have competed successfully for NIH and other federal funding, and who have interacted for many years in training and research activities. Extended research training is offered in a fellowship program designed to develop independent, funded investigators. Training opportunities have been enhanced by the setting with state-of-the-art research facilities, the recruitment of new, outstanding faculty members, and the awarding and/or renewal of program project grants in the areas of coagulation biology, gene transfer for hemophilia, and a Center for Excellence for Hematopoiesis. The program has emphasized the research training of minority students at all levels in order to increase the numbers of these individuals in biomedical careers. Despite a national trend away from pediatric subspecialty research training and toward clinical practice, the Pediatric Hematology Research Training Program continues to attract outstanding candidates and to prepare them for careers as biomedical investigators in academic institutions.

Public Health Relevance

Researchers in pediatric hematology play an important role in the diagnosis and treatment of common inherited disorders including sickle cell disease, thalassemia, and hemophilia. Better treatments for these diseases will improve the quality of life of affected individuals and will reduce admissions to children's hospitals, where 50% of all admissions are for inherited diseases such as these.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
2T32HL007150-36
Application #
8214332
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Chang, Henry
Project Start
1976-07-01
Project End
2017-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
36
Fiscal Year
2012
Total Cost
$117,138
Indirect Cost
$19,131
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Sullivan, Spencer K; Mills, Jason A; Koukouritaki, Sevasti B et al. (2014) High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombasthenia. Blood 123:753-7
Oshrine, Benjamin R; Olson, Timothy S; Bunin, Nancy (2014) Mixed chimerism and graft loss in pediatric recipients of an alemtuzumab-based reduced-intensity conditioning regimen for non-malignant disease. Pediatr Blood Cancer 61:1852-9
Paluru, Prasuna; Hudock, Kristin M; Cheng, Xin et al. (2014) The negative impact of Wnt signaling on megakaryocyte and primitive erythroid progenitors derived from human embryonic stem cells. Stem Cell Res 12:441-51
Oshrine, Benjamin R; Li, Yimei; Teachey, David T et al. (2013) Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood. Biol Blood Marrow Transplant 19:1581-9
Olson, Timothy S; Caselli, Anna; Otsuru, Satoru et al. (2013) Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning. Blood 121:5238-49
Caselli, Anna; Olson, Timothy S; Otsuru, Satoru et al. (2013) IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation. Stem Cells 31:2193-204
Zuber, Johannes; Rappaport, Amy R; Luo, Weijun et al. (2011) An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev 25:1628-40
Li, Hojun; Haurigot, Virginia; Doyon, Yannick et al. (2011) In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475:217-21
Blobel, Gerd A; Kadauke, Stephan; Wang, Eric et al. (2009) A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit. Mol Cell 36:970-83
Tripic, Tamara; Deng, Wulan; Cheng, Yong et al. (2009) SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood 113:2191-201

Showing the most recent 10 out of 27 publications